REPLAY: FDA Cellular, Tissue, and Gene Therapies Advisory Committee Meets on Biologics License for Deramiocel (Day 2)

By The Epoch Times | Created at 2026-07-30 14:41:49 | Updated at 2026-08-10 18:09:59 1 week ago

The FDA Cellular, Tissue, and Gene Therapies Advisory Committee meets at 9:30 a.m. ET on July 30 to discuss and make recommendations on Biologics License Application 125842 from Capricor Inc. for Deramiocel (human allogeneic cardiosphere-derived cells) in the treatment of cardiomyopathy in Duchenne muscular dystrophy.

Read Entire Article